Skip to content
Menu
About Us
Overview
Management Team
Board of Directors
Contact Us
Royalty Portfolio
Opportunities
Overview
Royalty Acquisition
Assets Available for Licensing
Phage Display Platform
IL-2 Antibody
Anti-prolactin Antibody
XMetA Portfolio
Anti-PTH1R Antibody
News
Company & Partner News
Press Releases
Investors
Overview
News & Events
Financial Information
Stock Data
Analyst Coverage
SEC Filings
Governance
Contact
Menu
About Us
Overview
Management Team
Board of Directors
Contact Us
Royalty Portfolio
Opportunities
Overview
Royalty Acquisition
Assets Available for Licensing
Phage Display Platform
IL-2 Antibody
Anti-prolactin Antibody
XMetA Portfolio
Anti-PTH1R Antibody
News
Company & Partner News
Press Releases
Investors
Overview
News & Events
Financial Information
Stock Data
Analyst Coverage
SEC Filings
Governance
Contact
IRS Form 8937
Investors
Investors
Overview
News & Events
Overview
Company & Partner News
Press Releases
IR Calendar
Email Alerts
Financial Information
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Overview
Charts
Historical Data
IRS Form 8937
Analyst Coverage
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Management Team
Board of Directors
Board Committees
Governance Documents
IRS Form 8937
Form 8937 Relating to Reverse Stock Split on October 17, 2016
Oct 31, 2016
Form 8937 Relating to Redomestication on December 31, 2011
Jan 16, 2012
Email Alerts
RSS News Feed
Scroll back to top
